CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS

CRIT REV THER DRUG
影响因子:2.5
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Begell House Inc.
发刊时间:1984
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:0743-4863

期刊介绍

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.
多种药物载体系统的治疗用途对许多慢性疾病的治疗和潜在治愈具有显著影响,所述慢性疾病包括癌症、糖尿病、牛皮癣、帕金森病、阿尔茨海默病、类风湿性关节炎、HIV感染、传染病、哮喘和药物成瘾。这些领域的科学研究是多学科的,涉及物理、生物、医学、制药、生物材料和工程等领域。有关这一领域的文章出现在各种各样的期刊上。随着文章数量的大量增加和科学碎片化的趋势,要跟上文献的发展并整理和评估数据的重要性和可靠性变得越来越困难,尤其是在涉及专有权考虑的情况下。摘要和非关键性文章通常不提供足够可靠的基础,以适当评估一个给定的领域,如果没有额外的阅读原始文献。该杂志通过发表权威、客观、全面的多学科评论论文来弥补这一差距,重点关注制剂和递送系统。邀请和投稿的文章都要经过同行评审。
年发文量 18
国人发稿量 0
国人发文占比 0%
自引率 -
平均录取率0
平均审稿周期 >12周,或约稿
版面费 -
偏重研究方向 医学-药学
期刊官网 http://dl.begellhouse.com/journals/3667c4ae6e8fd136.html
投稿链接 http://submission.begellhouse.com/usr/login.html?prod_code=journals

期刊高被引文献

Polymeric Mixed Micelles: Improving the Anticancer Efficacy of Single-Copolymer Micelles.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CritRevTherDrugCarrierSyst.2018020481
Polymeric Micelles for the Treatment of Rheumatoid Arthritis.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CRITREVTHERDRUGCARRIERSYST.2018021833
Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CritRevTherDrugCarrierSyst.2018025459
In Situ Forming Depot as Sustained-Release Drug Delivery Systems.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CritRevTherDrugCarrierSyst.2018025013
Long-Acting Injectables: Current Perspectives and Future Promise.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CritRevTherDrugCarrierSyst.2018025649
Inhalational Drug Delivery in Pulmonary Aspergillosis.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CRITREVTHERDRUGCARRIERSYST.2018025781
Dendrimers for Therapeutic Delivery: Compositions, Characterizations, and Current Status.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CRITREVTHERDRUGCARRIERSYST.2018025749
Current Developments in Therapeutic Drug Targeting for the Management of Rheumatoid Arthritis: An Emerging Paradigm.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/critrevtherdrugcarriersyst.2019025729
Solid Lipid Nanoparticles: Vital Characteristics and Prospective Applications in Cancer Treatment.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/critrevtherdrugcarriersyst.2019020396
Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/critrevtherdrugcarriersyst.2019027047
Evaluation of Nanocarrier-Based Dry Powder Formulations for Inhalation with Special Reference to Anti-Tuberculosis Drugs.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CritRevTherDrugCarrierSyst.2018024397
Theranostic Nanostructures for Ovarian Cancer.
来源期刊:Critical reviews in therapeutic drug carrier systemsDOI:10.1615/CRITREVTHERDRUGCARRIERSYST.2018025589

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
0.00%---

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q3区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q3

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2022年12月旧的升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区